Introduction
One of the main goals of research in immunology is to identify the origins of autoantibodies. A comprehensive solution of the problem will have to recognize that the predominant 4utoan-tibodies in most autoimmune diseases are tissue specific (Table  I) , whereas the autoantibodies in systematic lupus erythematosus (SLE)' react with numerous constituents of normal cells, including macromolecules as ubiquitous as DNA, cytoskeletal proteins, and phospholipids (Table II) (5, 6) , whereas others react with nuleosides (7), including cytidine and guanosine (8) . Munns et al. (9) demonstrated that all of the anti-single-stranded DNA activity of some sera from lupus-prone MRL-lpr/lpr and New Zealand Black/New Zealand White (NZB/NZW) mice was removed by absorption with a nucleoside-protein-Sepharose conjugate containing nucleosides of all four DNA bases; a guanosine conjugate removed 60% ofthe anti-single-stranded DNA activity and a thymidine conjugate removed 25%. However, the nucleosides did not absorb anti-double-stranded DNA antibodies.
Studies of the reactions of lupus sera with synthetic polynucleotides have revealed different populations of antibodies. Some react primarily with poly(dT), others with poly(dT) and single-stranded DNA, and still others with poly(dT), poly(dC), and single-stranded DNA (10) . Additional antibodies cross react with single-stranded DNA and the left-handed Z-helical DNA, or bind only to the Z-form (1 1). Lupus sera also contain antibodies that bind to other kinds of polynucleotides, including poly(A) (12), double-stranded RNA (13) , single-stranded RNA (14) , RNA-DNA hybrid (15) , and poly(ADP nrbose) (16). An important issue, in view of all of the above findings, is how to explain the apparent diversity of lupus autoantibodies even when only nucleic acid antigens are considered.
Polyspecificity ofmonoclonal anti-DNA autoantibodies. Im- (39) . One interpretation of the data is that the antibody-combining site has more than one contact region for unrelated epitopes. An alternative explanation is that certain epitopes, phosphodiester groups are a relevant example, recur in a variety of molecules. This kind of antigenic mimicry is exemplified by rheumatic carditis (40) and Chaga's disease (41) (56) . The -defect is selective because Z-DNA elicits high titers of specific antibodies in these animals. The curious lack of immunogenicity of DNA stands in contrast to the immunogenicity qf many other autoantigens, such as thyroglobulin and'the icetylcholine receptor, and raises the possibility that DNA is not the instigating antigen in SLE.
Could some unusual form'or fragment of DNA be the immunogen? Helical nucleic acid polymers other than B-DNA are immunogenic, but they induce antibodies specific for conformational features that differ from those of native DNA (with which they do not react) (57). Up to 2 mg/ml of serum antibody has been induced by double-stranded RNA, RNA-DNA hybrid, triple-helical polynucleotides (reviewed in 57), or by Z-DNA (55) . Weaker responses have been induced by right-handed polydeoxyribonucleotides that differ from B-DNA, such as poly(dG) * poly(dC) (58, 59) or poly(dC-dA) * poly(dTdG) (56) . In these cases, the antibodies probably recognize the conformation of the helical backbone and all of them are specific for the immunizing polynucleotide.
Low molecular weight DNA harvested from supernatants of cultured splenocytes can elicit anti-DNA antibodies in mice, but its immunogenicity is weak (60) . Low molecular weight DNA is also present in circulating immune complexes from lupus patients (61), perhaps because some anti-DNA antibodies can protect a 35-45 base-pair DNA fragment from DNase, thereby contributing to the formation of stable immune complexes (62) . ' Sano and Morimoto (63) proposed that DNA fragments with a high content 'of guanosine and cytosine, which they had identified in immune complexes, could be immunogenic. That is unlikely, however, because even pure poly(dG-dC) or poly(dG) * poly(dC) fail to induce antibodies to native DNA (55, 58, 59 ). An' altered form of DNA also develops following exposure of the molecule to UV light. Its antigenic determinant is the conformational distortion produced by the formation of thymine dimers (64) . It is plausible that UV-DNA could be immunogenic in SLE (65) the graft-versus-host reaction (70) . In the latter case, the antibodies react with both single-stranded and double-stranded DNA and the animals develop typical lesions of SLE.
The lpr gene has the same effect. It was originally identified in the MRL-lpr/lpr mouse and in that strain it causes massive lymphadenopathy, polyclonal activation of B cells, and an accelerated form of SLE (71) . The gene was subsequently transferred to several normal strains, in which it also induces the production of antibodies to double-stranded DNA (72) .
A striking example of the ability of B cells from normal persons to make anti-DNA antibodies has been reported by Cairns et al. (73) . They prepared hybridomas from the tonsillar lymphocytes of a normal 7-yr-old child. Growth occurred in 110 wells, of which 13 (11.8%) produced anti-DNA antibodies. Subclones ofthose hybridomas produced monoclonal antibodies with polyspecific ligand-binding properties that were indistinguishable from those of monoclonal lupus autoantibodies. In this case, it is important to note that the tonsillar lymphocytes had been activated in vivo by bacterial infection, an event we shall discuss below.
Structural clues. Amino acid sequence analyses of monoclonal anti-DNA antibodies have begun only recently, but important clues have already emerged. Eilat et al. (74) found that the amino terminal sequences of the heavy chain of a monoclonal anti-DNA antibody derived from an NZB/NZW mouse differed at only a single position from the corresponding sequences of an antibody to phosphocholine, an important bacterial antigen. Even more remarkable is the finding that a point mutation in the VH gene of a mouse myeloma changed the antigenic specificity of its immunoglobulin from antiphosphocholine to anti-DNA (75) .
Further evidence of a relationship between anti-DNA autoantibodies and anti-bacterial antibodies comes from structural studies of human antibodies. Four These genes seem to be widely dispersed in the population and they apparently have not diverged greatly from germline genes. They may be closely related to V genes whose products are involved in antibacterial responses. This could account for their conservation in the genome and for the observation that their corresponding antibodies differ from those elicited by immunogenic polynucleotides. With the availability of hybridomas that possess the appropriate genes, these hypotheses can be tested with molecular probes.
A major question concerns the stimulus for activation of these genes in SLE and the mechanism of their suppression in normal persons. Even if they represent only the fringes of an antibacterial response, are they stimulated by released nucleic acids, or by bacterial antigens, or by less specific polyclonal activators? Answers to these questions, along with definition of the target cell populations, could provide a more specific approach to control of this disease than is now available.
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